UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000021107
Receipt number R000024352
Scientific Title A phase I/IIa trial of docetaxel plus ribavirin for reprogramming efficacy in patients with progressive metastatic castration resistant prostate cancer who have previously received docetaxel alone
Date of disclosure of the study information 2016/03/01
Last modified on 2016/12/28 21:07:21

No. Disposal Last modified on Item of update
1 Insert 2016/02/19 17:19:54
2 Update 2016/02/19 17:29:58 Key inclusion criteria
3 Update 2016/02/29 16:10:19 Recruitment status
4 Update 2016/03/09 16:41:11 Key secondary outcomes
Key secondary outcomes
5 Update 2016/03/09 16:46:39 Interventions/Control_1
Interventions/Control_1
6 Update 2016/03/11 09:51:46 Interventions/Control_1
Interventions/Control_1
7 Update 2016/08/29 18:07:08 Last follow-up date
8 Update 2016/08/29 18:10:32 Address
Address
TEL
Address
Address
TEL
Name of primary person or sponsor
Organization
Organization
Category of Funding Organization
9 Update 2016/10/28 10:00:37 Institute
Institute
Department
10 Update 2016/12/28 21:07:21 Recruitment status
Last follow-up date
Date of closure to data entry